Laboratory Biomarker Analysis + Enzalutamide for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Nov 2017: Trial registered, NCT03344211
  2. 21 Nov 2018: Trial started, NCT03344211

The trials

NCT03344211: Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

State
Under way
Phase
Phase 2
People
30 taking part
Started
21 Nov 2018
Primary completion
31 Dec 2026
Arms
Arm II (enzalutamide)
Results
None posted
  1. 17 Nov 2017: Trial registered
  2. 21 Nov 2018: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.